Synthesis
Nucleotide Synthesis
DNA & RNA oligos with high modification + length capacity
Upgrading Automation in Solid-Phase Synthesis
The Ultimate Guide for Building Oligos
The Reagent Table of Nucleotides
- Antisense RNA Modifications
- Cellular Uptake Peptides
- Fluorescent Dyes
- Affinity Labels
- Degenerative (Mixed) Sets
Manufacturing is in the Genes
Experience and credibility play significant roles in bio scientific research. ChemGenes reagents have been tried and true for decades, contributing non-stop innovations to improve coupling efficiency and the structural capabilities of automated synthesis. Their proven quality and expertise make them not only the most qualified, but also the best partner to compliment kbDNA’s synthesis platform..
Patents & Trademarks
- 2’-O-Methyl, Ethyl phosphoramidite, patent #: US 6,015,886.
- 2’-O-Methyl patent, patent #: US 5,525,719.
- 3’-O-Methyl patent #: US 5,525,719.
- 2’-O-Propargyl modified, patent #: US 5,744,595.
- 3’-O-Propargyl modified Amidites & Solid Supports, patent #: US 5,744,595.
- 2’-Ara-O-methyl amidites, Patent #: US 20120149888.
- Reverse RNA synthesis, patent App #: WO 2011103468.
- Dithiolane based thiol modifier, patent Provisional application #: PCT61/79585.
- Oligonucleotide Labeling-Cycloaddition Reaction, Patent #: US 20120058476.
- Modifications of antimetabolite gemcitabine for incorporation in CpG oligonucleotides, Patent #: US 20110040082
- N6-Trimethyl-L-Lysine & derivative, their therapeutic uses, Patant #: US 20110166230; US 20110166231; US 20110166379; US 20110166380
Get Started Today
Nucleotide Synthesis Technology
Once you submit your inquiry - we'll review your submission and reply within 24 hours. Our response will include:
- The results of our free proofread, conducted by our expert chem-team.
- Recommendations for enhancing your oligos' performance based on your requirements.
- Quotes for both your original project submission, and a project utilizing our recommendations.
